474 related articles for article (PubMed ID: 25693791)
1. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Blanshard A; Hine P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
[TBL] [Abstract][Full Text] [Related]
4. Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Bukirwa H; Unnikrishnan B; Kramer CV; Sinclair D; Nair S; Tharyan P
Cochrane Database Syst Rev; 2014 Mar; (3):CD006404. PubMed ID: 24596021
[TBL] [Abstract][Full Text] [Related]
5. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Pryce J; Taylor M; Fox T; Hine P
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD006404. PubMed ID: 35726133
[TBL] [Abstract][Full Text] [Related]
6. Intermittent preventive treatment for malaria in infants.
Esu EB; Oringanje C; Meremikwu MM
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011525. PubMed ID: 34273901
[TBL] [Abstract][Full Text] [Related]
7. House modifications for preventing malaria.
Furnival-Adams J; Olanga EA; Napier M; Garner P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013398. PubMed ID: 33471371
[TBL] [Abstract][Full Text] [Related]
8. UK malaria treatment guidelines 2016.
Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials.
Assefa DG; Zeleke ED; Bekele D; Tesfahunei HA; Getachew E; Joseph M; Manyazewal T
Malar J; 2021 Apr; 20(1):174. PubMed ID: 33794897
[TBL] [Abstract][Full Text] [Related]
10. Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent
Stone W; Mahamar A; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Youssouf A; Diallo M; Soumare HM; Kaur H; Lanke K; Ter Heine R; Bradley J; Issiaka D; Diawara H; Traore SF; Bousema T; Drakeley C; Dicko A
Lancet Microbe; 2022 Jan; 3(1):e41-e51. PubMed ID: 35028628
[TBL] [Abstract][Full Text] [Related]
11. Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa.
van Beek SW; Svensson EM; Tiono AB; Okebe J; D'Alessandro U; Gonçalves BP; Bousema T; Drakeley C; Ter Heine R
Parasit Vectors; 2021 Oct; 14(1):524. PubMed ID: 34627346
[TBL] [Abstract][Full Text] [Related]
12. Topical repellents for malaria prevention.
Gabaldón Figueira JC; Wagah MG; Adipo LB; Wanjiku C; Maia MF
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD015422. PubMed ID: 37602418
[TBL] [Abstract][Full Text] [Related]
13. Mass drug administration for malaria.
Shah MP; Hwang J; Choi L; Lindblade KA; Kachur SP; Desai M
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD008846. PubMed ID: 34585740
[TBL] [Abstract][Full Text] [Related]
14. The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial.
Okebe J; Bousema T; Affara M; DiTanna G; Eziefula AC; Jawara M; Nwakanma D; Amambua-Ngwa A; Van Geertruyden JP; Drakeley C; D'Alessandro U
Trials; 2015 Mar; 16():70. PubMed ID: 25887344
[TBL] [Abstract][Full Text] [Related]
15. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data.
WWARN Gametocyte Study Group
BMC Med; 2016 May; 14():79. PubMed ID: 27221542
[TBL] [Abstract][Full Text] [Related]
16. Blocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysis.
Abay SM
Parasit Vectors; 2013 Sep; 6(1):278. PubMed ID: 24499628
[TBL] [Abstract][Full Text] [Related]
17. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
Rajasekhar M; Simpson JA; Ley B; Edler P; Chu CS; Abreha T; Awab GR; Baird JK; Bancone G; Barber BE; Grigg MJ; Hwang J; Karunajeewa H; Lacerda MVG; Ladeia-Andrade S; Llanos-Cuentas A; Pukrittayakamee S; Rijal KR; Saravu K; Sutanto I; Taylor WRJ; Thriemer K; Watson JA; Guerin PJ; White NJ; Price RN; Commons RJ;
Lancet Infect Dis; 2024 Feb; 24(2):184-195. PubMed ID: 37748497
[TBL] [Abstract][Full Text] [Related]
18. Pre-referral rectal artesunate for severe malaria.
Okebe J; Eisenhut M
Cochrane Database Syst Rev; 2014 May; 2014(5):CD009964. PubMed ID: 24869943
[TBL] [Abstract][Full Text] [Related]
19. Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data.
Stepniewska K; Allen EN; Humphreys GS; Poirot E; Craig E; Kennon K; Yilma D; Bousema T; Guerin PJ; White NJ; Price RN; Raman J; Martensson A; Mwaiswelo RO; Bancone G; Bastiaens GJH; Bjorkman A; Brown JM; D'Alessandro U; Dicko AA; El-Sayed B; Elzaki SE; Eziefula AC; Gonçalves BP; Hamid MMA; Kaneko A; Kariuki S; Khan W; Kwambai TK; Ley B; Ngasala BE; Nosten F; Okebe J; Samuels AM; Smit MR; Stone WJR; Sutanto I; Ter Kuile F; Tine RC; Tiono AB; Drakeley CJ; Gosling R; Stergachis A; Barnes KI; Chen I
BMC Med; 2022 Sep; 20(1):350. PubMed ID: 36109733
[TBL] [Abstract][Full Text] [Related]
20. Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.
Taylor WR; Olupot-Olupot P; Onyamboko MA; Peerawaranun P; Weere W; Namayanja C; Onyas P; Titin H; Baseke J; Muhindo R; Kayembe DK; Ndjowo PO; Basara BB; Bongo GS; Okalebo CB; Abongo G; Uyoga S; Williams TN; Taya C; Dhorda M; Tarning J; Dondorp AM; Waithira N; Fanello C; Maitland K; Mukaka M; Day NJP
Lancet Infect Dis; 2023 Apr; 23(4):471-483. PubMed ID: 36462528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]